News

Andrea Ventura
An Interview with Andrea Ventura

Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.

Monday, February 1, 2010
Samuel Singer
Samuel Singer Appointed Service Chief

Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.

Monday, February 1, 2010
Hedvig Hricak
Hedvig Hricak Named President of Radiological Society

Hedvig Hricak, Chair of Memorial Sloan Kettering’s Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.

Monday, February 1, 2010
Work of Postdoctoral Researchers Spotlighted at Third Annual Symposium

Each year since 2007, Memorial Sloan Kettering’s postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.

Monday, February 1, 2010
Timothy A. Chan
Researchers Link Gene that Causes Parkinson's Disease to Cancer

A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson’s disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer.

Monday, February 1, 2010
New Center Uses Mathematical Models to Understand Cancer

In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.

Monday, February 1, 2010
Joan Massagué
Self-Seeding of Cancer Cells May Play a Critical Role in Tumor Progression

Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called “self-seeding.

Thursday, December 24, 2009
Francis M. Sirotnak
FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering

Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.

Tuesday, December 1, 2009
James Allison
Researchers Design More Effective Cancer Vaccine

Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.

Tuesday, December 1, 2009
Investigators Pioneer a Cell-Based System for Modeling Disease and Treatment

Memorial Sloan Kettering researchers have engineered stem cells from patients with familial dysautonomia, a rare genetic disorder, and used them to explore the causes of the disease and to test drugs that might be effective against it.

Tuesday, December 1, 2009